机构:[1]Department of Clinical Research, Jinan University First Affiliated Hospital, Guangzhou, Guangdong, China.[2]School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.[3]Department of Chemotherapy and Radiation Therapy, Wuhan University Zhongnan Hospital, Wuhan, Hubei, China.[4]Shaanxi University of Chinese Medicine, Xianyang, China.[5]Xian Jiaotong University, Xi'an, China.
National Social Science Foundation of
China (grant no. 16BGL183).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|3 区医学
小类|3 区医学:内科
最新[2025]版:
大类|4 区医学
小类|4 区医学:内科
第一作者:
第一作者机构:[1]Department of Clinical Research, Jinan University First Affiliated Hospital, Guangzhou, Guangdong, China.[2]School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
通讯作者:
通讯机构:[1]Department of Clinical Research, Jinan University First Affiliated Hospital, Guangzhou, Guangdong, China.[2]School of Public Health, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
推荐引用方式(GB/T 7714):
Li Chengzhuo,Han Didi,Huang Qiao,et al.Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis.[J].BMJ open.2021,11(7):e048243.doi:10.1136/bmjopen-2020-048243.
APA:
Li Chengzhuo,Han Didi,Huang Qiao,Xu Fengshuo,Zheng Shuai...&Lyu Jun.(2021).Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis..BMJ open,11,(7)
MLA:
Li Chengzhuo,et al."Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis.".BMJ open 11..7(2021):e048243